omega-n-methylarginine has been researched along with adp beta s in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (adp beta s) | Trials (adp beta s) | Recent Studies (post-2010) (adp beta s) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 150 | 0 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dacey, RG; Dietrich, HH; Hongo, K; Horiuchi, T | 1 |
1 other study(ies) available for omega-n-methylarginine and adp beta s
| Article | Year |
|---|---|
Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arterioles; Brain; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen-Ion Concentration; In Vitro Techniques; Indomethacin; Male; Microscopy, Video; Nitric Oxide; omega-N-Methylarginine; Potassium Chloride; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Thionucleotides; Vascular Patency; Vasodilation | 2003 |